Because with our primary endpoint we are clinically significant by 14 days with primary endpoints , by this day also some placebo patients were better , so the statistical significance was just missed , if we will have little more patients in the study it will be good ,
but if you look at 3 days you will see significant difference between groups..

But our much more important in this study secondary endpoints-NEWS2 , we have statistical significance...

Those were excellent results in the study...but bashers do , what bashers do...


IMO...